Книга: Что скрывают противозачаточные. Как вернуть контроль над своими гормонами за 30 дней

Список литературы

1. О противозачаточных начистоту

Akinloye, O., et al. “Effects of Contraceptives on Serum Trace Elements, Calcium, and Phosphorus Levels”. West Indian Medical Journal 60, no. 3 (2011): 308–15.

Aminzadeh, A., et al. “Frequency of Candidiasis and Colonization of Candida Albicans in Relation to Oral Contraceptive Pills”. Iran Red Crescent Medical Journal 18, no. 10 (2016): e38909.

Anderson, K. E., et al. “Effects of Oral Contraceptives on Vitamin Metabolism”. Advances in Clinical Chemistry 18 (1976): 247–87.

Bird, S. T., et al. “Irritable Bowel Syndrome and Drospirenone-Containing Oral Contraceptives; A Comparative-Safety Study”. Current Drug Safety 7, no. 1 (2012): 8–15.

Centers for Disease Control, Cancer and Steroid Hormone Study. “Long-Term Oral Contraceptive Use and the Risk of Breast Cancer”. JAMA 249, no. 12 (1983): 1591–95.

Chasan-Taber, L., et al. “Epidemiology of Oral-Contraceptives and Cardiovascular Disease”. Annals of Internal Medicine 128, no. 6 (1998): 467–77.

Davidson, N. E., et al. “Good News About Oral Contraceptives”. New England Journal of Medicine 346 (2002): 2078–79.

Davis, A. R., et al. “Occurrence of Menses or Pregnancy After Cessation of a Continuous Oral Contraceptive”. Fertility and Sterility 89, no. 5 (2008): 1059–63.

Dreon, D. M., et al. “Oral Contraceptive Use and Increased Plasma Concentration of C-Reactive Protein”. Life Sciences 73, no. 10 (2003): 1245–52.

Dunn, N., et al. “Oral Contraceptives and Myocardial Infarction: Results of the MICA Case Control Study”. British Medical Journal 318, no. 7198 (1999): 1579–84.

Fröhlich, M., et al. “Oral Contraceptive Use Is Associated with a Systemic Acute Phase Response”. Fibrinolysis and Proteolysis 13, no. 6 (1999): 239–44.

Gingnell, M., et al. “Oral Contraceptive Use Changes Brain Activity and Mood in Women with Previous Negative Affect on the Pill – A Double-Blinded, Placebo-Controlled Randomized Trial of a Levonorgestrel-Containing Combined Oral Contraceptive”. Psychoneuroendocrinology 38, no. 7 (2013): 1133–44.

Hankinson, S. E., et al. “A Prospective Study of Oral Contraceptive Use and Risk of Breast Cancer (Nurses’ Health Study, United States)”. Cancer Causes and Control 8, no. 1 (1997): 65–72.

Hertel, J., et al. “Evidence for Stress-Like Alterations in the HPA-Axis in Women Taking Oral Contraceptives”. Scientific Reports 7, no. 1 (2017): 14111.

Hickman, R. J., et al. “C-Reactive Protein Is Elevated in Atypical but Not Nonatypical Depression: Data from the National Health and Nutrition Examination Survey (NHANES) 1999–2004”. Journal of Behavioral Medicine 37, no. 4 (2014): 621–29.

Hock, H. “The Pill and the College Attainment of American Women and Men”. Florida State University, September 15, 2005. http://paa2006.princeton.edu/papers/61745.

Jenkins, T. A., et al. “Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis”. Nutrients 8, no. 1 (2016): 56.

Khalili, H., et al. “Oral Contraceptives, Reproductive Factors, and Risk of Inflammatory Bowel Disease”. Gut 62, no. 8 (2013): 1153–59.

Khier, L. A. M. “Effects of Oral Contraceptives on the Thyroid Function in Sudanese Females”. BS thesis, University of Khartoum, 2000. https://core.ac.uk/download /pdf/71669046.pdf.

Kluf, C., et al. “Pro-Inflammatory Effects of Oestrogens During Use of Oral Contraceptives and Hormone Replacement Treatment”. Vascular Pharmacology 39, no. 3 (2002): 149–54.

Kulkami, J. “Depression as a Side Effect of the Contraceptive Pill”. Expert Opinion on Drug Safety 6, no. 4 (2007): 371–74.

Lewis, M. A., et al. “Third Generation Oral Contraceptives and Risk of Myocardial Infarction: An International Case-Control Study. Transnational Research Group on Oral Contraceptives and the Health of Young Women”. British Medical Journal 312, no. 7023 (1996): 88–90.

Maes, M., et al. “The Effects of Glucocorticoids on the Availability of L-Tryptophan and Tyrosine in the Plasma of Depressed Patients”. Journal of Affective Disorders 18, no. 2 (1990): 121–27. Marchbanks, P. A., et al. “Oral Contraceptives and the Risk of Breast Cancer”. New England Journal of Medicine 346 (2002): 2025–32.

Montoya, E. R., et al. “How Oral Contraceptives Impact Social-Emotional Behavior and Brain Function”. Trends in Cognitive Sciences 21, no. 2 (2017): 125–36.

Myint, A. M., et al. “The Role of the Kynurenine Metabolism in Major Depression”. Journal of Neural Transmission 119, no. 2 (2012): 245–51.

Nassaralla, C. L., et al. “Characteristics of the Menstrual Cycle after Discontinuation of Oral Contraceptives”. Journal of Women’s Health 20, no. 2 (2011): 169–77.

Oinonen, K. A., et al. “To What Extent Do Oral Contraceptives Influence Mood and Affect?” Journal of Affective Disorders 70, no. 3 (2002): 229–40.

“Oral-Contraceptive Use and the Risk of Breast Cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development”. New England Journal of Medicine 315, no. 7 (1986): 405–11.

Palan, P. R., et al. “Effects of Oral, Vaginal, and Transdermal Hormonal Contraception on Serum Levels of Coenzyme Q10, Vitamin E, and Total Antioxidant Activity”. Obstetrics and Gynaecology International (2010), article ID 925635.

Palmery, M., et al. “Oral Contraceptives and Changes in Nutritional Requirements”. European Review for Medical and Pharmacological Sciences 17, no. 13 (2013): 1804–13.

Panzer, C., et al. “Impact of Oral Contraceptives on Sex Hormone – Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction”. Journal of Sexual Medicine 3, no. 1 (2006): 104–13.

Park, B., et al. “Oral Contraceptive Use, Micronutrient Deficiency, and Obesity Among Premenopausal Females in Korea: The Necessity of Dietary Supplements and Food Intake Improvement”. PLoS One 11, no. 6 (2016): e0158177.

Peddie, B. A., et al. “Relationship Between Contraceptive Method and Vaginal Flora”. Australian and New Zealand Journal of Obstetrics and Gynaecology 24, no. 3 (1984): 217–18.

Piltonen, T., et al. “Oral, Transdermal, and Vaginal Combined Contraceptives Induce an Increase in Markers of Chronic Inflammation and Impair Insulin Sensitivity in Young Healthy Normal-Weight Women: A Randomized Study”. Human Reproduction 27, no. 10 (2012): 3046–56.

Rohr, U. D. “The Impact of Testosterone Imbalance on Depression and Women’s Health”. Maturitas 41, suppl. 1 (2002): S25–46.

Sarkar, M., et al. “Influence of Moonlight on the Birth of Male and Female Babies”. Nepal Medical College Journal 7, no. 1 (2005): 62–64.

Schatz, D. L., et al. “Effects of Oral Contraceptives and Pregnancy on Thyroid Function”. Canadian Medical Association Journal 99, no. 18 (1968): 882–86.

Schmidt, A., et al. “Oral Contraceptive Use and Vaginal Candida Colonization”. [In German.] Zentralbl Gynakol 119, no. 11 (1997): 545–49.

Shakerinejad, G., et al. “Factors Predicting Mood Changes in Oral Contraceptive Pill Users”. Reproductive Health 10 (2013): 45.

Skovlund, C. W., et al. “Association of Hormonal Contraception with Depression”. JAMA Psychiatry 73, no. 11 (2016): 1154–62.

Skovlund, C. W., et al. “Association of Hormonal Contraception with Suicide Attempts and Suicides”. American Journal of Psychiatry 175, no. 4 (2017): 336–42.

Smith, J. S., et al. “Cervical Cancer and Use of Hormonal Contraceptives: A Systematic Review”. Lancet 361, no. 9364 (2003): 1159–67.

Sorgdrager, F. J. H., et al. “The Association Between the Hypothalamic Pituitary Adrenal Axis and Tryptophan Metabolism in Persons with Recurrent Major Depressive Disorder and Healthy Controls”. Journal of Affective Disorders 222 (2017): 32–39.

Talukdar, N., et al. “Effect of Long-Term Combined Oral Contraceptive Pill Use on Endometrial Thickness”. Obstetrics and Gynecology 120, no. 2, pt. 1 (2012): 348–54.

Turna, B., et al. “Women with Low Libido: Correlation of Decreased Androgen Levels with Female Sexual Function Index”. International Journal of Impotence Research 17, no. 2 (2005): 148–53.

Van de Wijgert, J. H., et al. “Hormonal Contraception Decreases Bacterial Vaginosis but Oral Contraception May Increase Candidiasis: Implications for HIV Transmission”. AIDS 27, no. 13 (2013): 2141–53.

Van Hylckama Vlieg, A., et al. “The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the MEGA Case-Control Study”. British Medical Journal 339 (2009): b2921.

Vessey, M., et al. “Oral Contraceptive Use and Cancer. Findings in a Large Cohort Study, 1968–2004”. British Journal of Cancer 95, no. 3 (2006): 385–89.

Wang, Q., et al. “Effects of Hormonal Contraception on Systemic Metabolism: Cross-Sectional and Longitudinal Evidence”. International Journal of Epidemiology 45, no. 5 (2016): 1445–57.

Webb, J. L. “Nutritional Effects of Oral Contraceptive Use: A Review”. Journal of Reproductive Medicine 25, no. 4 (1980): 150–56.

White, T., et al. “Effects of Transdermal and Oral Contraceptives on Estrogen-Sensitive Hepatic Proteins”. Contraception 74, no. 4 (2006): 293–96.

Wiegratz, I., et al. “Effect of Four Different Oral Contraceptives on Various Sex Hormones and Serum-Binding Globulins”. Contraception 67, no. 1 (2003): 25–32.

Zimmerman, Y., et al. “The Effect of Combined Oral Contraception on Testosterone Levels in Healthy Women: A Systematic Review and Meta-Analysis”. Human Reproduction Update 20, no. 1 (2014): 76–105.

2. Вся правда о ваших гормонах

Adams, J. M., et al. “The Midcycle Gonadotropin Surge in Normal Women Occurs in the Face of an Unchanging Gonadotropin-Releasing Hormone Pulse Frequency”. Journal of Clinical Endocrinology and Metabolism 79 (1994): 858–64.

Baerwald, A. R., O. A. Olatunbosun, and R. A. Pierson. “Ovarian Follicular Development Is Initiated During the Hormone-Free Interval of Oral Contraceptive Use”. Contraception 70, no. 5 (2004): 371–77.

Cella, F., G. Giordano, and R. Cordera. “Serum Leptin Concentrations During the Menstrual Cycle in Normal-Weight Women: Effects of an Oral Triphasic Estrogen-Progestin Medication”. European Journal of Endocrinology 142 (2000): 174–78.

Clubb, E. “Natural Methods of Family Planning”. Journal of the Royal Society of Health 106, no. 4 (1986): 121–26.

Crosignani, P. G., et al. “Ovarian Activity During Regular Oral Contraceptive Use”. Contraception 54, no. 5 (1996): 271–73.

Davis, A. R., et al. “Occurrence of Menses or Pregnancy After Cessation of a Continuous Oral Contraceptive”. Fertility and Sterility 89, no. 5 (2008): 1059–63.

Filicori, M., J. P. Butler, and W. F. Crowley Jr. “Neuroendocrine Regulation of the Corpus Luteum in the Human. Evidence for Pulsatile Progesterone Secretion”. Journal of Clinical Investigation 73 (1984): 1638–47.

Filicori, M., N. Santoro, G. R. Merriam, and W. F. Crowley Jr. “Characterization of the Physiological Pattern of Episodic Gonadotropin Secretion Throughout the Human Menstrual Cycle”. Journal of Clinical Endocrinology and Metabolism 62 (1986): 1136–44.

Fleischer, A. C., G. C. Kalemeris, and S. S. Entman. “Sonographic Depiction of the Endometrium During Normal Cycles”. Ultrasound in Medicine and Biology 12, no. 4 (1986): 271–77.

Gipson, I. K., et al. “The Amount of MUC5B Mucin in Cervical Mucus Peaks at Midcycle”. Journal of Clinical Endocrinology and Metabolism 86, no. 2 (2001): 594–600.

Gougeon, A. “Dynamics of Follicular Growth in the Human: A Model from Preliminary Results”. Human Reproduction 1, no. 2 (1986): 81–87.

Gougeon A. “Dynamics of Human Follicular Growth: A Morphologic Perspective”. In The Ovary, edited by E. Y. Adashi and P. C. K. Leung (New York: Raven Press, 1993), p. 21.

Hall, J. E., D. A. Schoenfeld, K. A. Martin, and W. F. Crowley Jr. “Hypothalamic Gonadotropin-Releasing Hormone Secretion and Follicle-Stimulating Hormone Dynamics During the Luteal-Follicular Transition”. Journal of Clinical Endocrinology and Metabolism 74, no. 3 (1992): 600–7.

Jacobs, H. S., et al. “Post-‘Pill’ Amenorrhoea – Cause or Coincidence?” British Medical Journal 2, no. 6092 (1977): 940–42.

Kenealy, B. P., et al. “Neuroestradiol in the Hypothalamus Contributes to the Regulation of Gonadotropin Releasing Hormone Release”. Journal of Neuroscience 33, no. 49 (2013): 19051–9.

Knochenhauer, E., and R. Azziz. “Ovarian Hormones and Adrenal Androgens During a Woman’s Life Span”. Journal of the American Academy of Dermatology 45, suppl. 3 (2001): S105–15.

Milsom, I., and T. Korver. “Ovulation Incidence with Oral Contraceptives: A Literature Review”. BMJ Sexual and Reproductive Health 34, no. 4 (2008): 237–46.

Morrison, A. I. “Persistence of Spermatozoa in the Vagina and Cervix”. British Journal of Venereal Diseases 48, no. 2 (1972): 141–43.

Richards, J. S. “Hormonal Control of Gene Expression in the Ovary”. Endocrine Reviews 15, no. 6 (1994): 725–51.

Rosenberg, M. J., and M. S. Waugh. “Oral Contraceptive Discontinuation: A Prospective Evaluation of Frequency and Reasons”. American Journal of Obstetrics and Gynecology 179, no. 3 (1998): 577–82.

Sherman, B. M., and S. G. Korenman. “Hormonal Characteristics of the Human Menstrual Cycle Throughout Reproductive Life”. Journal of Clinical Investigation 55, no. 4 (1975): 699–706.

Simpson, E. R. “Sources of Estrogen and Their Importance”. Journal of Steroid Biochemistry and Molecular Biology 86, no. 3–5 (2003): 225–30.

Stocco, C., C. Telleria, and G. Gibori. «The Molecular Control of Corpus Luteum Formation, Function, and Regression”. Endocrine Reviews 28 (2007): 117–49.

Suarez, S. S., and A. A. Pacey. “Sperm Transport in the Female Reproductive Tract”. Human Reproduction Update 12, no. 1 (2006): 23–37.

Taylor, A. E., et al. “Midcycle Levels of Sex Steroids Are Sufficient to Recreate the Follicle-Stimulating Hormone but Not the Luteinizing Hormone Midcycle Surge: Evidence for the Contribution of Other Ovarian Factors to the Surge in Normal Women”. Journal of Clinical Endocrinology and Metabolism 80, no. 5 (1995): 1541–47.

Treloar, A. E., R. E. Boynton, B. G. Behn, and B. W. Brown. “Variation of the Human Menstrual Cycle Trough Reproductive Life”. International Journal of Fertility 12, no. 1, pt. 2 (1967): 77–126.

Tsafriri, A., S. Y. Chun, and R. Reich. “Follicular Rupture and Ovulation”. In The Ovary, edited by E. Y. Adashi and P. C. K. Leung (New York: Raven Press, 1993), p. 227.

Welt, C. K., et al. “Frequency Modulation of Follicle-Stimulating Hormone (FSH) During the Luteal-Follicular Transition: Evidence for FSH Control of Inhibin B in Normal Women”. Journal of Clinical Endocrinology and Metabolism 82, no. 8 (1997): 2645–52.

3. Синдром отмены противозачаточных

Behre, H. M., et al. “Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men”. Journal of Clinical Endocrinology and Metabolism 101, no. 12 (2016): 4779–88.

Boyle, N. B., et al. “The Effects of Magnesium Supplementation on Subjective Anxiety and Stress – A Systematic Review”. Nutrients 9, no. 5 (2017): 429.

Cormia, F. E. “Alopecia from Oral Contraceptives”. JAMA 201, no. 8 (1967): 635–37.

Darney, P. D. “OC Practice Guidelines: Minimizing Side Effects”. International Journal of Fertility and Women’s Medicine, Supplement 1 (1997): 158–69.

Gebel Berg, E. “The Chemistry of the Pill”. ACS Central Science 1, no. 1 (2015): 5–7.

Gnoth, C., et al. “Cycle Characteristics After Discontinuation of Oral Contraceptives”. Gynecological Endocrinology 16, no. 4 (2002): 307–17.

Grifths, W. A. D. “Diffuse Hair Loss and Oral Contraceptives”. British Journal of Dermatology 88, no. 1 (1973): 31–36.

Gröber, U., et al. “Magnesium in Prevention and Therapy”. Nutrients 7, no. 9 (2015): 8199–226.

Hammond, N., et al. “Nutritional Neuropathies”. Neurologic Clinics 31, no. 2 (2013): 477–89.

Johnson, S. “The Multifaceted and Widespread Pathology of Magnesium Deficiency”. Medical Hypotheses 56, no. 2 (2001): 163–70.

Kia, A. S., et al. “The Association Between the Risk of Premenstrual Syndrome and Vitamin D, Calcium, and Magnesium Status Among University Students: A Case Control Study”. Health Promotion Perspectives 5, no. 3 (2015): 225–30.

Lawrence, J. “NSAID Use May Prevent Fertile Women from Ovulating”. Pharmaceutical Journal 294, no. 7868/9 (2015).

McDowell, L. R. Vitamins in Animal and Human Nutrition. 2nd ed. Ames: Iowa State University Press, 2000, 265–310.

McIntosh, E. N. “Treatment of Women with the Galactorrhea-Amenorrhea Syndrome with Pyridoxine (Vitamin B6)”. Journal of Clinical Endocrinology and Metabolism 42, no. 6 (1976): 1192–95.

Mehta, K., et al. “Antiproliferative Effect of Curcumin (Diferuloylmethane) Against Human Breast Tumor Cell Line”. Anticancer Drugs 8, no. 5 (1997): 470–81.

Mendonça, L. L. F., et al. “Non-Steroidal Anti‐Inflammatory Drugs as a Possible Cause for Reversible Infertility”. Rheumatology 39, no. 8 (2000): 880–82.

Nabel, Elizabeth, G. “Coronary Heart Disease in Women – an Ounce of Prevention”. New England Journal of Medicine 343 (August 24, 2000): 572–74.

Parry, B. L., et al. “Oral Contraceptives and Depressive Symptomatology: Biologic Mechanisms”. Comprehensive Psychiatry 20, no. 4 (1979): 347–58.

Posaci, C., et al. “Plasma Copper, Zinc, and Magnesium Levels in Patients with Premenstrual Tension Syndrome”. Acta Obstetricia et Gynecologica Scandinavica 73, no. 6 (1994): 452–55.

Practice Committee of American Society for Reproductive Medicine. “Current Evaluation of Amenorrhea”. Fertility and Sterility 90, suppl. 5 (2008): S219–25.

Rajizadeh, A., et al. “Effect of Magnesium Supplementation on Depression Status in Depressed Patients with Magnesium Deficiency: A Randomized, Double-Blind, Placebo-Controlled Trial”. Nutrition 35 (2017): 56–60.

Ramos, P. M., et al. “Female Pattern Hair Loss: A Clinical and Pathophysiological Review”. Anais Brasileiros de Dermatologia 90, no. 4 (2015): 529–43.

Roberts, S. C., et al. “MHC–Correlated Odour Preferences in Humans and the Use of Oral Contraceptives”. Proceedings of the Royal Society B: Biological Sciences 275, no. 1652 (2008): 2715–22.

Rojas-Walsson, R., et al. “Diagnosis and Management of Post-Pill Amenorrhea”. Journal of Family Practice 13, no. 2 (1981): 165–69.

Stewart, M. E., et al. “Effect of Cyproterone Acetate-Ethinyl Estradiol Treatment on the Proportions of Linoleic and Sebaleic Acids in Various Skin Surface Lipid Classes”. Archives of Dermatological Research 278, no. 6 (1986): 481–85.

University of Pennsylvania School of Medicine. “Two Thirds of Women Interested in Stopping Their Periods but Unsure About Safety”. ScienceDaily. October 4, 2007.

Wang, J. G., et al. “The Complex Relationship Between Hypothalamic Amenorrhea and Polycystic Ovary Syndrome”. Journal of Clinical Endocrinology and Metabolism 93, no. 4 (2008): 1394–97.

Wedekind, C., et al. “Body Odour Preferences in Men and Women: Do They Aim for Specific MHC Combinations or Simply Heterozygosity?” Proceedings of the Royal Society B: Biological Sciences 264, no. 1387 (1997): 1471–79.

Wyatt, K. M., et al. “Efficacy of Vitamin B-6 in the Treatment of Premenstrual Syndrome: Systematic Review”. British Medical Journal 318, no. 7195 (1999): 1375–81.

4. Верните себе свои месячные

American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. “Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign”. Committee Opinion No. 651. December 2015. https://www.acog.org/-/media/Committee – Opinions/Committee-on-Adolescent-Health-Care/co651.pdf?dmc=1&ts=20180626 T0442019822.

Bouchard, C., et al. “Use of Oral Contraceptive Pills and Vulvar Vestibulitis: A Case-Control Study”. American Journal of Epidemiology 156, no. 3 (2002): 254–61.

Goldstein, A. T., et al. “Polymorphisms of the Androgen Receptor Gene and Hormonal Contraceptive Induced Provoked Vestibulodynia”. Journal of Sexual Medicine 11, no. 11 (2014): 2764–71.

5. Азбука детоксикации от гормональных контрацептивов

Baum, J. K., et al. “Possible Association Between Benign Hepatomas and Oral Contraceptives”. Lancet 2, no. 7835 (1973): 926–29.

Blackwell. “Oral Contraceptive Pill May Prevent More than Pregnancy: Could Cause Long-Term Problems with Testosterone”. ScienceDaily.com. January 5, 2006.

https:// www.sciencedaily.com/releases/2006/01/060104232338.htm.

Bradlow, H. L., et al. “Multifunctional Aspects of the Action of Indole-3-Carbinol as an Antitumor Agent”. Annals of the New York Academy of Sciences 889 (1999): 204–13.

Bradlow, H. L., et al. “2-Hydroxyestrone: The ‘Good’ Estrogen”. Journal of Endocrinology 150 suppl. (1996): S259–65.

Dawling, S., et al. “Catechol-o-methyltransferase (COMT)-Mediated Metabolism of Catechol Estrogens: Comparison of Wild-Type and Variant COMT Isoforms”. Cancer Research 61, no. 18 (2001): 6716–22.

De Waal, E. J., et al. “Differential Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Bis(tri-n butyltin) Oxide, and Cyclosporine on Thymus Histophysiology”. Critical Reviews in Toxicology 27, no. 4 (1997): 381–430.

Edmondson, H. A., et al. “Liver-Cell Adenomas Associated with Use of Oral Contraceptives”. New England Journal of Medicine 294, no. 9 (1976): 470–72.

Eramo, S., et al. “Estrogenicity of Bisphenol A Released from Sealants and Composites: A Review of the Literature”. Annali di Stomatologia 1, nos. 3–4 (2010): 14–21.

Etminan, M., et al. “Oral Contraceptives and the Risk of Gallbladder Disease: A Comparative Safety Study”. Canadian Medical Association Journal 183, no. 8 (2011): 899–904.

Fishman, W. H. “Beta-Glucuronidase in the Metabolic Conjugation of Estrogenic Hormones”. Federation Proceedings 6, no. 1, pt. 2 (1947): 251.

Fowke, J. H., et al. “Brassica Vegetable Consumption Shifts Estrogen Metabolism in Healthy Postmenopausal Women”. Cancer Epidemiology, Biomarkers and Prevention 9, no. 8 (2000): 773–79.

Hofmann, A. F. “The Continuing Importance of Bile Acids in Liver and Intestinal Disease”. Archives of Internal Medicine 159, no. 22 (1999): 2647–58.

Klatskin, G. “Hepatic Tumors: Possible Relationship to Use of Oral Contraceptives”. Gastroenterology 73, no. 2 (1977): 386–94.

Kuhl, H., et al. “The Effect of Sex Steroids and Hormonal Contraceptives upon Thymus and Spleen on Intact Female Rats”. Contraception 28, no. 6 (1983): 587–601.

Lord, R. S., et al. “Estrogen Metabolism and the Diet-Cancer Connection: Rationale for Assessing the Ratio of Urinary Hydroxylated Estrogen Metabolites”. Alternative Medicine Review 7, no. 2 (2002): 112–29.

Marciani, L., et al. “Effects of Various Food Ingredients on Gallbladder Emptying”. European Journal of Clinical Nutrition 67, no. 11 (2013): 1182–87.

McCann, S. E., et al. “Changes in 2-Hydroxyestrone and 16α-Hydroxyestrone Metabolism with Flaxseed Consumption: Modification by COMT and CYP1B1 Genotype”. Cancer Epidemiology, Biomarkers and Prevention 16, no. 2 (2007): 256–62.

Meissner, K. “Hemorrhage Caused by Ruptured Liver Cell Adenoma Following Long-Term Oral Contraceptives: A Case Report”. Hepatogastroenterology 45, no. 19 (1998): 224–25. Mueck, A. O., et al. “Estradiol Metabolism and Malignant Disease”. Maturitas 43, no. 1 (2002): 1–10.

Muti, P., et al. “Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16Alpha-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women”. Epidemiology 11, no. 6 (2000): 635–40.

Nime, F., et al. “The Histology of Liver Tumors in Oral Contraceptive Users Observed During a National Survey by the American College of Surgeons Commission on Cancer”. Cancer 44, no. 4 (1979): 1481–89.

Nwachukwu, J. C., et al. “Resveratrol Modulates the Inflammatory Response Via an Estrogen Receptor-Signal Integration Network”. Elife 3 (2014): e02057.

Oredipe, O. A., et al. “Dietary Glucarate-Mediated Inhibition of Initiation of Diethyl-nitrosamine-Induced Hepatocarcinogenesis”. Toxicology 74, nos. 2–3 (1992): 209–22.

Prigge, J. R., et al. “Hepatocyte DNA Replication in Growing Liver Requires Either Glutathione or a Single Allele of TXNRD1”. Free Radical Biology and Medicine 52, no. 4 (2012): 803–10.

Racine, A., et al. “Menopausal Hormone Therapy and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort”. Canadian Medical Association Journal 185, no. 7 (2013): 555–61.

Rafogianis, R., et al. “Estrogen Metabolism by Conjugation”. Journal of the National Cancer Institute Monographs 27 (2000): 113–24.

Rooks, J. B., et al. “Epidemiology of Hepatocellular Adenoma. The Role of Oral Contraceptive Use”. JAMA 242, no. 7 (1979): 644–48.

Rosenberg, L. “The Risk of Liver Neoplasia in Relation to Combined Oral Contraceptive Use”. Contraception 43, no. 6 (1991): 643–52.

Ruotolo, R., et al. “Anti-Estrogenic Activity of a Human Resveratrol Metabolite”. Nutrition, Metabolism, and Cardiovascular Diseases 23, no. 11 (2013): 1086–92.

Schuurman, H. J., et al. “Chemicals Trophic for the Thymus: Risk for Immunodeficiency and Autoimmunity”. International Journal of Immunopharmacology 14, no. 3 (1992): 369–75.

Shortell, C. K., et al. “Hepatic Adenoma and Focal Nodular Hyperplasia”. Surgery, Gynecology, and Obstetrics 173, no. 5 (1991): 426–31.

Søe, K. L., et al. “Liver Pathology Associated with the Use of Anabolic-Androgenic Steroids”. Liver 12, no. 2 (1992): 73–79.

Steiner, J. L., et al. “Dose-Dependent Benefits of Quercetin on Tumorigenesis in the C3(1)/ SV40Tag Transgenic Mouse Model of Breast Cancer”. Cancer Biology and Therapy 15, no. 11 (2014): 1456–67.

Ursin, G., et al. “Urinary 2-Hydroxyestrone/16Alpha-Hydroxyestrone Ratio and Risk of Breast Cancer in Postmenopausal Women”. Journal of the National Cancer Institute 91, no. 12 (1999): 1067–72.

Wallwiener, C. W., et al. “Prevalence of Sexual Dysfunction and Impact of Contraception in Female German Medical Students”. Journal of Sexual Medicine 7, no. 6 (2010): 2139–48.

Wu, Z., et al. “Progesterone Inhibits L-Type Calcium Currents in Gall Bladder Smooth Muscle Cells”. Journal of Gastroenterology and Hepatology 25, no. 12 (2010): 1838–43.

Yang, C. Z., et al. “Most Plastic Products Release Estrogenic Chemicals: A Potential Health Problem Tat Can Be Solved”. Environmental Health Perspectives 119, no. 7 (2011): 989–96.

Zhang, L. Q., et al. “Potential Therapeutic Targets for the Primary Gallbladder Carcinoma: Estrogen Receptors”. Asian Pacific Journal of Cancer Prevention 14, no. 4 (2013): 2185–90.

6. Оздоровление кишечника

Adlercreutz, H., et al. “Studies on the Role of Intestinal Bacteria in Metabolism of Synthetic and Natural Steroid Hormones”. Journal of Steroid Biochemistry 20, no. 1 (1984): 217–29.

Ashraf, M., et al. “The Presence of Anti-Thyroid and Anti-Ovarian Auto-Antibodies in Familial Premature Ovarian Failure”. International Journal of Fertility and Sterility 1, no. 4 (2008): 171–74.

Bast, A., et al. “Celiac Disease and Reproductive Health”. Practical Gastroenterology 35, no. 10 (2009): 10–21.

Bernier, M. O., et al. “Combined Oral Contraceptive Use and the Risk of Systemic Lupus Erythematosus”. Arthritis and Rheumatology 61, no. 4 (2009): 476–81.

Blasi, F., et al. “The Effect of N-Acetylcysteine on Biofilms: Implications for the Treatment of Respiratory Tract Infections”. Respiratory Medicine 117 (2016): 190–97.

Bultman, S. J. “The Microbiome and Its Potential as a Cancer Preventive Intervention”. Seminars in Oncology 43, no. 1 (2016): 97–106.

Campana, R., et al. “Strain-Specific Probiotic Properties of Lactic Acid Bacteria and Their Interference with Human Intestinal Pathogens Invasion”. Gut Pathogens 9, no. 1 (2017): 12.

Cook, L. C., et al. “The Role of Estrogen Signaling in a Mouse Model of Inflammatory Bowel Disease: A Helicobacter Hepaticus Model”. PLoS One 9, no. 4 (2014): e94209.

Costenbader, K. H., et al. “Reproductive and Menopausal Factors and Risk of Systemic Lupus Erythematosus in Women”. Arthritis and Rheumatology 56, no. 4 (2007): 1251–62.

Crujeiras, A. B., et al. “Leptin Resistance in Obesity: An Epigenetic Landscape”. Life Sciences 140 (2015): 57–63.

Cummings, S. R., et al. “Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk”. Journal of the National Cancer Institute 101, no. 6 (2009): 384–98.

Cutolo, M., et al. “Estrogens and Autoimmune Diseases”. Annals of the New York Academy of Sciences 1089 (2006): 538–47.

Dai, Z. L., et al. “L-Glutamine Regulates Amino Acid Utilization by Intestinal Bacteria”. Amino Acids 45, no. 3 (2013): 501–12.

De Kort, S., et al. “Leaky Gut and Diabetes Mellitus: What Is the Link?” Obesity Reviews 12, no. 6 (2011): 449–58.

Dinicola, S., et al. “N-Acetylcysteine as Powerful Molecule to Destroy Bacterial Biofilms. A Systematic Review”. European Review for Medical and Pharmacological Sciences 18, no. 19 (2014): 2942–48.

Divi, R. L., et al. “Anti-thyroid Isoflavones from Soybean: Isolation, Characterization, and Mechanisms of Action”. Biochemical Pharmacology 54, no. 10 (1997): 1087–96.

Engen, P. A., et al. “The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota”. Alcohol Research 37, no. 2 (2015): 223–36.

Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. “Contraceptive Choices for Women with Inflammatory Bowel Disease”. Journal of Family Planning and Reproductive Health Care 29, no. 3 (2003): 127–35. http://srh.bmj.com /content/familyplanning/29/3/127.full.pdf.

Fasano, A. “Leaky Gut and Autoimmune Diseases”. Clinical Reviews in Allergy and Immunology 42, no. 1 (2012): 71–78.

Fasano, A. “Zonulin, Regulation of Tight Junctions, and Autoimmune Diseases”. Annals of the New York Academy of Sciences 1258 (2012): 25–33.

Fasano, A., et al. “Mechanisms of Disease: The Role of Intestinal Barrier Function in the Pathogenesis of Gastrointestinal Autoimmune Diseases”. Nature Clinical Practice. Gastroenterology and Hepatology 2, no. 9 (2005): 416–22.

Fénichel, P., et al. “Prevalence, Specificity, and Significance of Ovarian Antibodies During Spontaneous Premature Ovarian Failure”. Human Reproduction 12, no. 12 (1997): 2623–28.

Fresko, I., et al. “Anti-Saccharomyces Cerevisiae Antibodies (ASCA) in Behçet’s Syndrome”. Clinical and Experimental Rheumatology 23, suppl. 38 (2005): S67–70.

Frieri, M. “Neuroimmunology and Inflammation: Implications for Therapy of Allergic and Autoimmune Diseases”. Annals of Allergy, Asthma, and Immunology 90, no. 6, suppl. 3 (2003): S34–40.

Gameiro, C. M., et al. “Menopause and Aging: Changes in the Immune System – A Review”. Maturitas 67, no. 4 (2010): 316–20.

Gawron, L., et al. “Oral Contraceptive Use and Crohn’s Disease Complications”. Gastroenterology 151, no. 5 (2016): 1038–39.

https://www.gastrojournal.org/article/S0016-5085 (16)35072-7/fulltext?code=ygast-site.

Harmon, Q. E., et al. “Use of Estrogen-Containing Contraception Is Associated with Increased Concentrations of 25-Hydroxy Vitamin D”. Journal of Clinical Endocrinology and Metabolism 101, no. 9 (2016): 3370–77. https://academic.oup.com/jcem/article /101/9/3370/2806637.

Hartmann, P., et al. “The Intestinal Microbiome and the Leaky Gut as Therapeutic Targets in Alcoholic Liver Disease”. Frontiers in Physiology 3 (2012): 402.

Hu, M. L., et al. “Effect of Ginger on Gastric Motility and Symptoms of Functional Dyspepsia”. World Journal of Gastroenterology 17, no. 1 (2011): 105–10.

Jacobsen, B. K., et al. “Soy Isoflavone Intake and the Likelihood of Ever Becoming a Mother: The Adventist Health Study-2”. International Journal of Women’s Health 6 (2014): 377–84.

Jeferson, W. N. “Adult Ovarian Function Can Be Affected by High Levels of Soy”. Journal of Nutrition 140, no. 12 (2010): 2322S–25S.

Jessop, D. S., et al. “Effects of Stress on Inflammatory Autoimmune Disease: Destructive or Protective?” Stress 7, no. 4 (2004): 261–66.

Khalili, H., et al. “Association Between Long-Term Oral Contraceptive Use and Risk of Crohn’s Disease Complications in a Nationwide Study”. Gastroenterology 150, no. 7 (2016): 1561–67.e1. https://www.gastrojournal.org/article/S00165085(16)002328/fulltext?code=ygast-site.

Khalili, H., et al. “Oral Contraceptives, Reproductive Factors, and Risk of Inflammatory Bowel Disease”. Gut 62, no. 8 (2013): 1153–59.

Khalili, H., et al. “Sa1231 Oral Contraceptive Use and Risk of Surgery Among Crohn’s Patients”. Gastroenterology 148, no. 4, suppl. 1 (2015): S264–65.

Kwa, M., et al. “The Intestinal Microbiome and Estrogen Receptor – Positive Female Breast Cancer”. Journal of the National Cancer Institute 108, no. 8 (2016).

Long, M. D., et al. “Shifting Away from Estrogen-Containing Oral Contraceptives in Crohn’s Disease”. Gastroenterology 150, no. 7 (2016): 1518–20.

Luborsky, J., et al. “Ovarian Antibodies, FSH, and Inhibin B: Independent Markers Associated with Unexplained Infertility”. Human Reproduction 15, no. 5 (2000): 1046–51.

Lyngsø, J., et al. “Association Between Coffee or Caffeine Consumption and Fecundity and Fertility: A Systematic Review and Dose-Response Meta-Analysis”. Clinical Epidemiology 9 (2017): 699–719.

McMichael-Phillips, D. F., et al. “Effects of Soy-Protein Supplementation on Epithelial Proliferation in the Histologically Normal Human Breast”. American Journal of Clinical Nutrition 68, suppl. 6 (1998): 1431S–35.

Mulak, A., et al. “Sex Hormones in the Modulation of Irritable Bowel Syndrome”. World Journal of Gastroenterology 20, no. 10 (2014): 2433–48.

Petrakis, N. L., et al. “Stimulatory Influence of Soy Protein Isolate on Breast Secretion in Pre- and Postmenopausal Women”. Cancer Epidemiology, Biomarkers, and Prevention 5, no. 10 (1996): 785–94.

Petri, M., et al. “Oral Contraceptives and Systemic Lupus Erythematosus”. Arthritis and Rheumatism 40, no. 5 (1997): 797–803.

Quah, S. Y., et al. “N-Acetylcysteine Inhibits Growth and Eradicates Biofilm of Enterococcus Faecalis”. Journal of Endodontics 38, no. 1 (2012): 81–85.

Rizzo, G., et al. “Soy, Soy Foods, and Their Role in Vegetarian Diets”. Nutrients 10, no. 1 (2018): 43.

Schliep, K. C., et al. “Caffeinated Beverage Intake and Reproductive Hormones Among Premenopausal Women in the BioCycle Study”. American Journal of Clinical Nutrition 95, no. 2 (2012): 488–97.

Scrimgeour, A. G., et al. “Zinc and Micronutrient Combinations to Combat Gastrointestinal Inflammation”. Current Opinion in Clinical Nutrition and Metabolic Care 12, no. 6 (2009): 653–60.

Sieron, D., et al. “The Effect of Chronic Estrogen Application on Bile and Gallstone Composition in Women with Cholelithiasis”. Minerva Endocrinologica 41, no. 1 (2016): 19–27.

Skrovanek, S., et al. “Zinc and Gastrointestinal Disease”. World Journal of Gastrointestinal Pathophysiology 5, no. 4 (2014): 496–513.

Stojanovich, L., et al. “Stress as a Trigger of Autoimmune Disease”. Autoimmunity Reviews 7, no. 3 (2008): 209–13.

Sun, C. L., et al. “Dietary Soy and Increased Risk of Bladder Cancer: The Singapore Chinese Health Study”. Cancer Epidemiology, Biomarkers, and Prevention 11, no. 12 (2002): 1674–77.

Tayyebi-Khosroshahi, H., et al. “Effect of Treatment with Omega-3 Fatty Acids on C-Reactive Protein and Tumor Necrosis Factor-Alfa in Hemodialysis Patients”. Saudi Journal of Kidney Diseases and Transplantation 23, no. 3 (2012): 500–6.

Torne Research. “Calcium-D-Glucarate”. Alternative Medicine Review 7, no. 4 (2002): 336–39.

Tralau, T., et al. “Insights on the Human Microbiome and Its Xenobiotic Metabolism: What Is Known About Its Effects on Human Physiology?” Expert Opinion on Drug Metabolism and Toxicology 11, no. 3 (2015): 411–25.

Tung, K. S. K., et al. “Mechanisms of Autoimmune Disease in the Testis and Ovary”. Human Reproduction Update 1, no. 1 (1995): 35–50.

Vojdani, A., et al. “Cross-Reaction Between Gliadin and Different Food and Tissue Antigens”. Food and Nutrition Sciences 4, no. 1 (2013): 20–32.

Wang, B., et al. “Glutamine and Intestinal Barrier Function”. Amino Acids 47, no. 10 (2015): 2143–54.

Wang, B., et al. “L-Glutamine Enhances Tight Junction Integrity by Activating CaMK Kinase 2-AMP-Activated Protein Kinase Signaling in Intestinal Porcine Epithelial Cells”. Journal of Nutrition 146, no. 3 (2016): 501–8.

White, L., et al. “Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study”. JAMA 276, no. 12 (1996): 955–60.

Williams, W. V. “Hormonal Contraception and the Development of Autoimmunity: A Review of the Literature”. Linacre Quarterly 84, no. 3 (2017): 275–95.

Yan, Y., et al. “Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder Trough Inhibition of NLRP3 Inflammasome Activation”. Immunity 38, no. 6 (2013): 1154–63.

Yang, Q., et al. “Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults”. JAMA Internal Medicine 174, no. 4 (2014): 516–24.

https://jamanetwork.com /journals/jamainternalmedicine/fullarticle/1819573.

Yates, C. M., et al. “Pharmacology and Therapeutics of Omega-3 Polyunsaturated Fatty Acids in Chronic Inflammatory Disease”. Pharmacology and Therapeutics 141, no. 3 (2014): 272–82.

Zhao, T., et al. “N-Acetylcysteine Inhibit Biofilms Produced by Pseudomonas Aeruginosa”. BMC Microbiology 10 (2010): 140.

Zitvogel, L. “Cancer and the Gut Microbiota: An Unexpected Link”. Science Translational Medicine 7, no. 271 (2015): 271ps1.

7. Зарядите свою щитовидную железу и надпочечники

Ajjan, R., et al. “The Pathogenesis of Hashimoto’s Thyroiditis: Further Developments in Our Understanding”. Hormone and Metabolic Research 47, no. 10 (2015): 702–10.

Alexander, E. K., et al. “2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum”. Thyroid 27, no. 3 (2017): 315–89. https://www.liebertpub.com/doi/pdfplus/10.1089/thy.2016.0457.

Ayhan, M. G., et al. “The Prevalence of Depression and Anxiety Disorders in Patients with Euthyroid Hashimoto’s Thyroiditis: A Comparative Study”. General Hospital Psychiatry 36, no. 1 (2014): 95–98.

Bajaj, J. K., et al. “Various Possible Toxicants Involved in Thyroid Dysfunction: A Review”. Journal of Clinical and Diagnostic Research 10, no. 1 (2016): FE01–03.

Balázs, C., et al. “Effect of Selenium on HLA-DR Expression of Thyrocytes”. Autoimmune Diseases (2012), article ID 374635.

Ban, Y., et al. “The Contribution of Immune Regulatory and Thyroid Specific Genes to the Etiology of Graves’ and Hashimoto’s Diseases”. Autoimmunity 36, nos. 6–7 (2003): 367–79.

Ban, Y., et al. “Genetic Susceptibility in Thyroid Autoimmunity”. Pediatric Endocrinology Reviews 3, no. 1 (2005): 20–32.

Blackwell, J. “Evaluation and Treatment of Hyperthyroidism and Hypothyroidism”. Journal of the American Association of Nurse Practitioners 16, no. 10 (2004): 422–25.

Bunevicius, A., et al. “Hypothalamic-Pituitary-Thyroid Axis Function in Women with a Menstrually Related Mood Disorder”. Psychosomatic Medicine 74, no. 8 (2012): 810–16.

Caturegli, P., et al. “Autoimmune Thyroid Diseases”. Current Opinion in Rheumatology 19, no. 1 (2007): 44–48.

Cauci, S., et al. “Effects of Third-Generation Oral Contraceptives on High-Sensitivity C-Reactive Protein and Homocysteine in Young Women”. Obstetrics and Gynecology 111, no. 4 (2008): 857–64.

Chandrasekhar, K., et al. “A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of a High-Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults”. Indian Journal of Psychological Medicine 34, no. 3 (2012): 255–62.

Checchi, S., et al. “L-Thyroxine Requirement in Patients with Autoimmune Hypothyroidism and Parietal Cell Antibodies”. Journal of Clinical Endocrinology and Metabolism 93, no. 2 (2008): 465–69.

Ch’ng, C. L., et al. “Celiac Disease and Autoimmune Thyroid Disease”. Clinical Medicine and Research 5, no. 3 (2007): 184–92.

Cojocaru, M., et al. “Multiple Autoimmune Syndrome”. Maedica 5, no. 2 (2010): 132–34. Contempre, B., et al. “Effect of Selenium Supplementation in Hypothyroid Subjects of an Iodine and Selenium Deficient Area: The Possible Danger of Indiscriminate Supplementation of Iodine-Deficient Subjects with Selenium”. Journal of Endocrinology and Metabolism 73, no. 1 (1991): 213–15.

Daher, R., et al. “Consequences of Dysthyroidism on the Digestive Tract and Viscera”. World Journal of Gastroenterology 15, no. 23 (2009): 2834–38.

Dama, M., et al. “Thyroid Peroxidase Autoantibodies and Perinatal Depression Risk: A Systematic Review”. Journal of Affective Disorders 198 (2016): 108–21.

De Herder, W. W., et al. “On the Enterohepatic Cycle of Triiodothyronine in Rats; Importance of the Intestinal Microflora”. Life Sciences 45, no. 9 (1989): 849–56.

Divani, A. A., et al. “Effect of Oral and Vaginal Hormonal Contraceptives on Inflammatory Blood Biomarkers”. Mediators of Inflammation (2015), article ID 379501.

Drutel, A., et al. “Selenium and the Thyroid Gland: More Good News for Clinicians”. Clinical Endocrinology 78, no. 2 (2013): 155–64.

Ebert, E. C. “The Thyroid and the Gut”. Journal of Clinical Gastroenterology 44, no. 6 (2010): 402–6.

Fan, Y., et al. “Selenium Supplementation for Autoimmune Thyroiditis: A Systematic Review and Meta-Analysis”. International Journal of Endocrinology 2014, no. 1 (2014): 904573.

Fisher, D. A. “Physiological Variations in Thyroid Hormones: Physiological and Pathophysiological Considerations”. Clinical Chemistry 42, no. 1 (1996): 135–39.

Foster, J. A., et al. “Stress and the Gut-Brain Axis: Regulation by the Microbiome”. Neurobiology of Stress 7 (2017): 124–36.

Gärtner, R., et al. “Selenium Supplementation in Patients with Autoimmune Thyroiditis Decreases Thyroid Peroxidase Antibodies Concentrations”. Journal of Clinical Endocrinology and Metabolism 87, no. 4 (2002): 1687–91.

Gerenova, J., et al. “Clinical Significance of Autoantibodies to Parietal Cells in Patients with Autoimmune Thyroid Diseases”. Folia Medica 55, no. 2 (2013): 26–32.

Gierach, M., et al. “Hashimoto’s Thyroiditis and Carbohydrate Metabolism Disorders in Patients Hospitalised in the Department of Endocrinology and Diabetology of Ludwik Rydygier Collegium Medicum in Bydgoszcz Between 2001 and 2010”. Endokrynologia Polska 63, no. 1 (2012): 14–17.

Girdler, S. S., et al. “Historical Sexual Abuse and Current Thyroid Axis Profiles in Women with Premenstrual Dysphoric Disorder”. Psychosomatic Medicine 66, no. 3 (2004): 403–10.

Gorini, P., et al. “The Stimulating Effect of a Cytosol Extract from Regenerating Liver on Isolated Hepatocytes and the Positive Role of Insulin”. Italian Journal of Surgical Sciences 18, no. 3 (1988): 201–5.

Guggenheim, A. G., et al. “Immune Modulation from Five Major Mushrooms: Application to Integrative Oncology”. Integrative Medicine 13, no. 1 (2014): 32–44.

Guhad, F. A., et al. “Salivary IgA as a Marker of Social Stress in Rats”. Neuroscience Letters 216, no. 2 (1996): 137–40.

Haugen, B. R. “Drugs that Suppress TSH or Cause Central Hypothyroidism”. Best Practice and Research. Clinical Endocrinology and Metabolism 23, no. 6 (2009): 793–800.

Hays, M. T. “Thyroid Hormone and the Gut”. Endocrine Research 14, nos. 2–3 (1988): 203–24.

Houston, M. “The Role of Magnesium in Hypertension and Cardiovascular Disease”. Journal of Clinical Hypertension 13, no. 11 (2011): 843–47.

Hybenova, M., et al. “The Role of Environmental Factors in Autoimmune Thyroiditis”. Neuro Endocrinology Letters 31, no. 3 (2010): 283–89.

Kahaly, G. J., et al. “Thyroid Hormone Action in the Heart”. Endocrine Reviews 26, no. 5 (2005): 704–28. https://academic.oup.com/edrv/article/26/5/704/2355198.

Kakuno, Y., et al. “Menstrual Disturbances in Various Thyroid Diseases”. Endocrine Journal 57, no. 12 (2010): 1017–22.

Keely, E. J. “Postpartum Thyroiditis: An Autoimmune Thyroid Disorder Which Predicts Future Thyroid Health”. Obstetric Medicine 4, no. 1 (2011): 7–11.

Kimura, H., et al. “Chemokine Orchestration of Autoimmune Thyroiditis”. Thyroid 17, no. 10 (2007): 1005–11.

Kloosterboer, H. J., et al. “Effects of Tree Low-Dose Contraceptive Combinations on Sex Hormone – Binding Globulin, Corticosteroid Binding Globulin and Antithrombin III Activity in Healthy Women: Two Monophasic Desogestrel Combinations (Containing 0.020 or 0.030 mg Ethinylestradiol) and One Triphasic Levonorgestrel Combination”. Acta Obstetricia et Gynecologica Scandinavica 66, suppl. 143 (1987): 41–44.

Koutras, D. A. “Disturbances of Menstruation in Thyroid Disease”. Annals of the New York Academy of Sciences 816 (1997): 280–84.

Krassas, G. E. “Thyroid Disease and Female Reproduction”. Fertility and Sterility 74, no. 6 (2000): 1063–70.

Lauritano, E., et al. “Association Between Hypothyroidism and Small Intestinal Bacterial Overgrowth”. Journal of Clinical Endocrinology and Metabolism 92, no. 11 (2007): 4180–84.

Mackawy, A. M. H., et al. “Vitamin D Deficiency and Its Association with Thyroid Disease”. International Journal of Health Sciences 7, no. 3 (2013): 267–75.

Mansournia, N., et al. “The Association Between Serum 25OHD Levels and Hypothyroid Hashimoto’s Thyroiditis”. Journal of Endocrinological Investigation 37, no. 5 (2014): 473–76.

Olsson, E. M. G., et al. “A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Standardised Extract SHR-5 of the Roots of Rhodiola Rosea in the Treatment of Subjects with Stress-Related Fatigue”. Planta Medica 75 (2009): 105–12.

Ongphiphadhanakul, B., et al. “Tumor Necrosis Factor-Alpha Decreases Thyrotropin-Induced 5’-Deiodinase Activity in FRTL-5 Thyroid Cells”. European Journal of Endocrinology 130, no. 5 (1994): 502–7.

Palmery, M., et al. “Oral Contraceptives and Changes in Nutritional Requirements”. European Review for Medical and Pharmacological Sciences 17, no. 13 (2013): 1804–13.

Peterson, A. M., et al. “The Anti-Inflammatory Effect of Exercise”. Journal of Applied Physiology 98, no. 4 (2005): 1154–62.

Ramya, M. R., et al. “Menstrual Disorders Associated with Thyroid Dysfunction”. International Journal of Reproduction, Contraception, Obstetrics, and Gynecology 6, no. 11 (2017): 5113–17. http://www.ijrcog.org/index.php/ijrcog/article/viewFile /3718/2946.

Rettori, V., et al. “Central Action of Interleukin-1 in Altering the Release of TSH, Growth Hormone, and Prolactin in the Male Rat”. Journal of Neuroscience Research 18, no. 1 (1987): 179–83.

Sapolsky, R. M., et al. “The Neuroendocrinology of Stress and Aging: The Glucocorticoid Cascade Hypothesis”. Endocrine Reviews 7, no. 3 (1986): 284–301.

Sørensen, C. J., et al. “Combined Oral Contraception and Obesity Are Strong Predictors of Low Grade Inflammation in Healthy Individuals: Results from the Danish Blood Donor Study (DBDS)”. PLoS One 9, no. 2 (2014): e88196.

Stagnaro-Green, A. “Approach to the Patient with Postpartum Thyroiditis”. Journal of Clinical Endocrinology and Metabolism 97, no. 2 (2012): 334–42.

Steingold, K. A., “Comparison of Transdermal to Oral Estradiol Administration on Hormonal Hepatic Parameters in Women with Premature Ovarian Failure”. Journal of Clinical Endocrinology and Metabolism 73, no. 2 (1991): 275–80.

Stojanovich, L., et al. “Stress as a Trigger of Autoimmune Disease”. Autoimmunity Reviews 7, no. 3 (2008): 209–13.

Surks, M. I., et al. “Drugs and Thyroid Function”. New England Journal of Medicine 333, no. 25 (1995): 1688–94.

Torp, V. J. “Effect of Oral Contraceptive Agents on Vitamins and Mineral Requirements”. Journal of the American Dietetic Association 76, no. 6 (1980): 581–84.

Verlarde-Mayol, C., et al. “Pernicious Anemia and Autoimmune Thyroid Disease in Elderly People”. [In Spanish.] Revista Española de Geriatría y Gerontología 50, no. 3 (2015): 126–28.

Walter, K. N., et al. “Elevated Thyroid Stimulating Hormone Is Associated with Elevated Cortisol in Healthy Young Men and Women”. Thyroid Research 5 (2012): 13.

Webb, J. L. “Nutritional Effects of Oral Contraceptive Use: A Review”. Journal of Reproductive Medicine 25, no. 4 (1980): 150–56. Westhof, C., et al. “Using Changes in Binding Globulins to Assess Oral Contraceptive Compliance”. Contraception 87, no. 2 (2013): 176–81.

Woodruf, S. C., et al. “Mindfulness and Anxiety”. In The Wiley Blackwell Handbook of Mindfulness, edited by A. Ie, C. T. Ngnoumen, and E. J. Langer, ch. 37. New York: John Wiley, 2014.

8. Разберите свой метаболический кавардак

Abdollahi, M., et al. “Obesity: Risk of Venous Thrombosis and the Interaction with Coagulation Factor Levels and Oral Contraceptive Use”. Thrombosis and Haemostasis 89, no. 3 (2003): 493–98.

Alvarez, J. A., et al. “Role of Vitamin D in Insulin Secretion and Insulin Sensitivity for Glucose Homeostasis”. International Journal of Endocrinology (2010): 351385.

Bakir, R., et al. “Lipids, Lipoproteins, Arterial Accidents, and Oral Contraceptives”. [In French.] Contraception, Fertilité, Sexualité 14, no. 1 (1986): 81–87.

Bloemenkamp, K. W., et al. “Risk of Venous Thrombosis with Use of Current Low-Dose Oral Contraceptives Is Not Explained by Diagnostic Suspicion and Referral Bias”. Archives of Internal Medicine 159, no. 1 (1999): 65–70.

Bultman, S. J. “Emerging Roles of the Microbiome in Cancer”. Carcinogenesis 35, no. 2 (2014): 249–55.

Bushnell, C. D. “Stroke in Women: Risk and Prevention Throughout the Lifespan”. Neurologic Clinics 26, no. 4 (2008): 1161-xi.

Cauci, S., et al. “Effects of Third-Generation Oral Contraceptives on High-Sensitivity C-Reactive Protein and Homocysteine in Young Women”. Obstetrics and Gynecology 111, no. 4 (2008): 857–64.

Centers for Disease Control. “Long – Term Oral Contraceptive Use and the Risk of Breast Cancer. The Centers for Disease Control Cancer and Steroid Hormone Study”. JAMA 249, no. 12 (1983): 1591–95.

Chasan-Taber, L., et al. “Epidemiology of Oral Contraceptives and Cardiovascular Disease”. Annals of Internal Medicine 128, no. 6 (1998): 467–77.

Chen, L., et al. “Mechanisms Linking Inflammation to Insulin Resistance”. International Journal of Endocrinology (2015): 508409.

Cummings, S. R., et al. “Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk”. Journal of the National Cancer Institute 101, no. 6 (2009): 384–98.

De Bastos, M., et al. “Combined Oral Contraceptives: Venous Thrombosis”. Cochrane Database of Systematic Reviews 3, no. 3 (2014): CD010813.

De Bruijn, S. F., et al. “Case-Control Study of Risk of Cerebral Sinus Thrombosis in Oral Contraceptive Users and in [Correction of Who Are] Carriers of Hereditary Prothrombotic Conditions. The Cerebral Venous Sinus Thrombosis Study Group”. British Medical Journal 316, no. 7131 (1998): 589–92.

Diab, K. M., et al. “Contraception in Diabetic Women: Comparative Metabolic Study of Norplant, Depot Medroxyprogesterone Acetate, Low Dose Oral Contraceptive Pill and CuT380A”. Journal of Obstetrics and Gynaecology Research 26, no. 1 (2000): 17–26.

Dinger, J. C., et al. “The Safety of a Drospirenone-Containing Oral Contraceptive: Final Results from the European Active Surveillance Study on Oral Contraceptives Based on 142,475 Women – Years of Observation”. Contraception 75, no. 5 (2007): 344–54.

Duarte, C., et al. “Oral Contraceptives and Systemic Lupus Erythematosus: What Should We Advise to Our Patients?” Acta Reumatológica Portuguesa 35, no. 2 (2010): 133–40. European Medicines Agency. “PhVWP Monthly Report on Safety Concerns, Guidelines, and General Matters”. No. 1201 (January 2012). http://www.ema.europa.eu/docs/en_GB /document_library/Report/2012/01/WC500121387.pdf.

Fang, X., et al. “Dose-Response Relationship Between Dietary Magnesium Intake and Cardiovascular Mortality: A Systemic Review and Dose-Based Meta-Regression Analysis of Prospective Studies”. Journal of Trace Elements in Medicine and Biology 38 (2016): 64–73.

Glintborg, D. “Increased Thrombin Generation in Women with Polycystic Ovary Syndrome: A Pilot Study on the Effect of Metformin and Oral Contraceptives”. Metabolism 64, no. 10 (2015): 1272–78.

Greenlund, K. J., et al. “Associations of Oral Contraceptive Use with Serum Lipids and Lipoproteins in Young Women: The Bogalusa Heart Study”. Annals of Epidemiology 7, no. 8 (1997): 561–67.

Haarala, A., et al. “Use of Combined Oral Contraceptives Alters Metabolic Determinants and Genetic Regulation of C-Reactive Protein. The Cardiovascular Risk in Young Finns Study”. Scandinavian Journal of Clinical and Laboratory Investigation 69, no. 2 (2009): 168–74.

Hankinson, S. E., et al. “A Prospective Study of Oral Contraceptive Use and Risk of Breast Cancer (Nurses’ Health Study, United States)”. Cancer Causes and Control 8, no. 1 (1997): 65–72.

Houston, M. “The Role of Magnesium in Hypertension and Cardiovascular Disease”. Journal of Clinical Hypertension 13, no. 11 (2011): 843–47.

Kalkhof, R. K. “Effects of Oral Contraceptive Agents and Sex Steroids on Carbohydrate Metabolism”. Annual Review of Medicine 23 (1972): 429–38.

Kemmeren, J. M., et al. “Effect of Second- and Third-Generation Oral Contraceptives on the Protein C System in the Absence or Presence of the Factor V Leiden Mutation: A Randomized Trial”. Blood 103, no. 3 (2004): 927–33.

Kemmeren, J. M., et al. “Effects of Second- and Third-Generation Oral Contraceptives and Their Respective Progestagens on the Coagulation System in the Absence or Presence of the Factor V Leiden Mutation”. Thrombosis and Haemostasis 87, no. 2 (2002): 199–205.

Kim, Sung-Woo, et al. “Long-Term Effects of Oral Contraceptives on the Prevalence of Diabetes in Post-menopausal Women: 2007–2012 KNHANES”. Endocrine 53, no. 3 (2016): 816–22.

Kjos, S. L., et al. “Contraception and the Risk of Type 2 Diabetes Mellitus in Latina Women with Prior Gestational Diabetes Mellitus”. JAMA 280, no. 6 (1998): 533.

Krauss, R. M., et al. “The Metabolic Impact of Oral Contraceptives”. American Journal of Obstetrics and Gynecology 167, no. 4, pt. 2 (1992): 1177–84.

Kuhl, H. “Hormonal Contraception and Substitution Therapy: The Importance of Progestogen for Cardiovascular Diseases”. [In German.] Geburtshilfe und Frauenheilkunde 52, no. 11 (1992): 653–62.

Larivée, N., et al. “Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters”. Drug Safety 40, no. 7 (2017): 583–96.

Lizarelli, P. M., et al. “Both a Combined Oral Contraceptive and Depot Medroxyprogesterone Acetate Impair Endothelial Function in Young Women”. Contraception 79, no. 1 (2009): 35–40.

Lobo, R. A., et al. “The Importance of Diagnosing the Polycystic Ovary Syndrome”. Annals of Internal Medicine 132, no. 12 (2000): 989–93.

Lydic, M. L., et al. “Chromium Picolinate Improves Insulin Sensitivity in Obese Subjects with Polycystic Ovary Syndrome”. Fertility and Sterility 86, no. 1 (2006): 243–46.

Macik, B. G., et al. “Thrombophilia: What’s a Practitioner to Do?” Hematology, American Society of Hematology Education Program (2001): 322–38. http://asheducationbook.hematologylibrary.org/content/2001/1/322.full.pdf.

Marchbanks, P. A., et al. “Oral Contraceptives and the Risk of Breast Cancer”. New England Journal of Medicine 346 (2002): 2025–32.

Martinelli, I., et al. “High Risk of Cerebral-Vein Thrombosis in Carriers of a Prothrombin-Gene Mutation and in Users of Oral Contraceptives”. New England Journal of Medicine 338, no. 25 (1998): 1793–97.

Martinelli, I., et al. “Hyperhomocysteinemia in Cerebral Vein Thrombosis”. Blood 102, no. 4 (2003): 1363–66.

Martinelli, I., et al. “Interaction Between the G20210A Mutation of the Prothrombin Gene and Oral Contraceptive Use in Deep Vein Thrombosis”. Arteriosclerosis, Thrombosis, and Vascular Biology 19, no. 3 (1999): 700–3.

Mavropoulos, J. C., et al. “The Effects of a Low-Carbohydrate, Ketogenic Diet on the Polycystic Ovary Syndrome: A Pilot Study”. Nutrition and Metabolism 2 (2005): 35.

Merki-Feld, G. S. “Effect of Combined Hormonal Contraceptives on the Vascular Endothelium and New Cardiovascular Risk Parameters”. [In German.] Therapeutische Umschau 66, no. 2 (2009): 89–92.

Middeldorp, S., et al. “Effects on Coagulation of Levonorgestrel- and Desogestrel-Containing Low Dose Oral Contraceptives: A Cross-Over Study”. Thrombosis and Haemostasis 84, no. 1 (2000): 4–8.

Moghadam, A. M., et al. “Efficacy of Omega-3 Fatty Acid Supplementation on Serum Levels of Tumor Necrosis Factor-Alpha, C-Reactive Protein and Interleukin-2 in Type 2 Diabetes Mellitus Patients”. Singapore Medical Journal 53, no. 9 (2012): 615–19.

Mohllajee, A. P., et al. “Does Use of Hormonal Contraceptives Among Women with Thrombogenic Mutations Increase Their Risk of Venous Thromboembolism? A Systematic Review”. Contraception 73, no. 2 (2006): 166–78.

Moreno, V., et al. “Effect of Oral Contraceptives on Risk of Cervical Cancer in Women with Human Papillomavirus Infection: The IARC Multicentric Case-Control Study”. Lancet 359, no. 9312 (2002): 1085–92.

Murray, E. K. I., et al. “Thromboelastographic Identifies Cyclic Haemostatic Variations in Healthy Women Using Oral Contraceptives”. Thrombosis Research 136, no. 5 (2015): 1022–26.

Nestler, J. E., et al. “Ovulatory and Metabolic Effects of D-chiro-inositol in the Polycystic Ovary Syndrome”. New England Journal of Medicine 340, no. 17 (1999): 1314–20.

Nightingale, A. L., et al. “The Effects of Age, Body Mass Index, Smoking, and General Health on the Risk of Venous Thromboembolism in Users of Combined Oral Contraceptives”. European Journal of Contraception and Reproductive Health Care 5, no. 4 (2000): 265–74.

Nordio, M., et al. “The Combined Therapy with Myo-inositol and D-chiro-inositol Reduces the Risk of Metabolic Disease in PCOS Overweight Patients Compared to Myo-inositol Supplementation Alone”. European Review for Medical and Pharmacological Sciences 16, no. 5 (2012): 575–81.

Oner, G., et al. “Clinical, Endocrine, and Metabolic Effects of Metformin vs. N-Acteylcytseine in Women with Polycystic Ovary Syndrome”. European Journal of Obstetrics, Gynecology, and Reproductive Biology 159, no. 1 (2011): 127–31.

“Oral – Contraceptive Use and the Risk of Breast Cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development”. New England Journal of Medicine 315, no. 7 (1986): 405–11.

Orio, F., et al. “Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome”. Minerva Ginecologica 60, no. 1 (2008): 39–51.

Pelusi, B., et al. “Type 2 Diabetes and the Polycystic Ovary Syndrome”. Minerva Ginecologica 56, no. 1 (2004): 41–51.

Pomp, E. R., et al. “Risk of Venous Thrombosis: Obesity and Its Joint Effect with Oral Contraceptive Use and Prothrombotic Mutations”. British Journal of Haematology 139, no. 2 (2007): 289–96.

Raghuramulu, N., et al. “Vitamin D Improves Oral Glucose Tolerance and Insulin Secretion in Human Diabetes”. Journal of Clinical Biochemistry and Nutrition 13, no. 1 (1992): 45–51.

Raitakari, M., et al. “Distribution and Determinants of Serum High-Sensitive C-Reactive Protein in a Population of Young Adults: The Cardiovascular Risk in Young Finns Study”. Journal of Internal Medicine 258, no. 5 (2005): 428–34.

Roach, R. E., et al. “Combined Oral Contraceptives: The Risk of Heart Attack and Stroke in Women Using Birth Control Pills”. Cochrane Database of Systematic Reviews no. 8 (2015): CD011054. Roberfroid, M., et al. “Prebiotic Effects: Metabolic and Health Benefits”. British Journal of Nutrition 104, suppl. 2 (2010): S1–63.

Rocha, S. L., et al. “Heart Attack in a Young Woman – All About Genetics!” Journal of US- China Medical Science 14 (2017): 28–30.

https://www.davidpublisher.com/Public /uploads/Contribute/58b7979d5aba9.pdf.

Rosing, J., et al. “Low-Dose Oral Contraceptives and Acquired Resistance to Activated Protein C: A Randomised Cross-over Study”. Lancet 354, no. 9195 (1999): 2036–40.

Rosing, J., et al. “Oral Contraceptives and Venous Thrombosis: Different Sensitivities to Activated Protein C in Women Using Second- and Third-Generation Oral Contraceptives”. British Journal of Haematology 97, no. 1 (1997): 233–38. Samsioe, G. “Coagulation and Anticoagulation Effects of Contraceptive Steroids”. American Journal of Obstetrics and Gynecology 170, no. 5, pt. 2 (1994): 1523–27.

Samsunnahar, Q. S. A., et al. “Assessment of Coagulation Disorder in Women Taking Oral Contraceptives”. Journal of Bangladesh Society of Physiologist 9, no. 1 (2014): 1–5.

Sasieni, P. “Cervical Cancer Prevention and Hormonal Contraception”. Lancet 370, no. 9599 (2007): 1591–92.

Seeger, J. D., et al. “Risk of Thromboembolism in Women Taking Ethinylestradiol/ Drospirenone and Other Oral Contraceptives”. Obstetrics and Gynecology 110, no. 3 (2007): 587–93.

Shoelson, S. E., et al. “Inflammation and Insulin Resistance”. Journal of Clinical Investigation 116, no. 7 (2006): 1793–1801.

Sidney, S., et al. “Venous Thromboembolic Disease in Users of Low-Estrogen Combined Estrogen-Progestin Oral Contraceptives”. Contraception 70, no. 1 (2004): 3–10.

Singh, B., et al. “Resveratrol Inhibits Estrogen-Induces Breast Carcinogenesis Trough Induction of NRF2-Mediated Protective Pathways”. Carcinogenesis 35, no. 8 (2014): 1872–80.

Skouby, S. O., et al. “Contraception for Women with Diabetes: An Update”. Bailliére’s Clinical Obstetrics and Gynaecology 5, no. 2 (1991): 493–503.

Smith J. S., et al. “Cervical Cancer and Use of Hormonal Contraceptives: A Systematic Review”. Lancet 361, no. 9364 (2003): 1159–67.

Soares, G. M., et al. “Metabolic and Cardiovascular Impact of Oral Contraceptives in Poly cystic Ovary Syndrome”. International Journal of Clinical Practice 63, no. 1 (2009): 160–69.

Sørensen, C. J., et al. “Combined Oral Contraception and Obesity Are Strong Predictors of Low-Grade Inflammation in Healthy Individuals: Results from the Danish Blood Donor Study (DBDS)”. PLoS One 9, no. 2 (2014): e88196.

Tys-Jacobs, S., et al. “Vitamin D and Calcium Dysregulation in the Polycystic Ovarian Syndrome”. Steroids 64, no. 6 (1999): 430–35.

Vandenbroucke, J. P., et al. “Increased Risk of Venous Thrombosis in Oral-Contraceptive Users Who Are Carriers of Factor V Leiden Mutation”. Lancet 344, no. 8935 (1994): 1453–57.

Van Hylckama, V. A., et al. “The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the MEGA Case-Control Study”. British Medical Journal 339 (2009): b2921. Vasilakis, C., et al. “Risk of Idiopathic Venous Thromboembolism in Users of Progestagens Alone”. Lancet 354, no. 9190 (1999): 1610–11.

Vasilakis, C., et al. “The Risk of Venous Thromboembolism in Users of Postcoital Contraceptive Pills”. Contraception 52, no. 2 (1999): 79–83.

Vessey, M., et al. “Oral Contraceptive Use and Cancer. Findings in a Large Cohort Study 1968–2004”. British Journal of Cancer 95, no. 3 (2006): 385–89.

Vinogradova, Y., et al. “Use of Combined Oral Contraceptives and Risk of Venous Tromboembolism: Nested Case-Control Studies Using the QResearch and CPRD Databases”. British Medical Journal 350 (2015): h2135.

Wang, Q., et al. “Effects of Hormonal Contraception on Systemic Metabolism: Cross- Sectional and Longitudinal Evidence”. International Journal of Epidemiology 45, no. 5 (2016): 1445–57.

Westhof, C. L., et al. “Clotting Factor Changes During the First Cycle of Oral Contraceptive Use”. Contraception 93, no. 1 (2016): 70–76.

Williams, M. J., et al. “Association Between C-Reactive Protein, Metabolic Cardiovascular Risk Factors, Obesity, and Oral Contraceptive Use in Young Adults”. International Journal of Obesity and Related Metabolic Disorders 28, no. 8 (2004): 998–1003.

Yan, Y., et al. “Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder Trough Inhibition of NLRP3 Infammasome Activation”. Immunity 38, no. 6 (2013): 1154–63.

9. Возьмите под контроль свои перепады настроения, тревожное расстройство и депрессию

Akhondzadeh, S., et al. “Passionfower in the Treatment of Generalized Anxiety: A Pilot Double-Blind Randomized Controlled Trial with Oxazepam”. Journal of Clinical Pharmacy and Therapeutics 26, no. 5 (2001): 363–67.

Almey, A., et al. “Estrogen Receptors in the Central Nervous System and Their Implication for Dopamine-Dependent Cognition in Females”. Hormones and Behavior 74 (2015): 125–38.

Anxiety and Depression Association of America. “Facts & Statistics”. https://adaa.org/about-adaa/press-room/facts-statistics#.

Arbo, B. D., et al. “Effect of Low Doses of Progesterone in the Expression of the GABA(A) Receptor α4 Subunit and Procaspase-3 in the Hypothalamus of Female Rats”. Endocrine 46, no. 3 (2014): 561–67.

Arevalo, M. A., et al. “Selective Oestrogen Receptor Modulators Decrease the Inflammatory Response of Glial Cells”. Journal of Neuroendocrinology 24, no. 1 (2012): 183–90.

Bay-Richter, C., et al. “A Role for Inflammatory Metabolites as Modulators of the Glutamate N-Methyl-D-Aspartate Receptor in Depression and Suicidality”. Brain, Behavior, and Immunity 43 (2015): 110–17.

Borrow, A. P., et al. “Estrogenic Mediation of Serotonergic and Neurotrophic Systems: Implications for Female Mood Disorders”. Progress in Neuropsychopharmacology and Biological Psychiatry 54 (2014): 13–25.

Bos, P. A., et al. “Acute Effects of Steroid Hormones and Neuropeptides on Human Social – Emotional Behavior: A Review of Single Administration Studies”. Frontiers in Neuroendocrinology 33, no. 1 (2012): 17–35.

Bouma, E. M. C., et al. “Adolescents’ Cortisol Responses to Awakening and Social Stress; Effects of Gender, Menstrual Phase, and Oral Contraceptives. The TRAILS Study”. Psychoneuroendocrinology 34, no. 6 (2009): 884–93.

Brinton, R. D., et al. “Progesterone Receptors: Form and Function in Brain”. Frontiers in Neuroendocrinology 29, no. 2 (2008): 313–39.

Bunevicius, A., et al. “Hypothalamic-Pituitary-Thyroid Axis Function in Women with a Menstrually Related Mood Disorder: Association with Histories of Sexual Abuse”. Psychosomatic Medicine 74, no. 8 (2012): 810–16.

Carta, M. G., et al. “The Link Between Thyroid Autoimmunity (Antithyroid Peroxidase Autoantibodies) with Anxiety and Mood Disorders in the Community: A Field of Interest or Public Health in the Future”. BMC Psychiatry 4, no. 1 (2004): 25.

Catuzzi, J. E., et al. “Anxiety Vulnerability in Women: A Two-Hit Hypothesis”. Experimental Neurology 259 (2014): 75–80.

Daniel, K., et al. “Contraceptive Methods Women Have Ever Used: United States, 1982–2010”. National Health Statistics Reports 62 (2013): 1–15. https://www.cdc.gov/nchs/data/nhsr/nhsr062.pdf.

Deac, O. M., et al. “Tryptophan Catabolism and Vitamin B-6 Status Are Affected by Gender and Lifestyle Factors in Healthy Young Adults”. Journal of Nutrition 145, no. 4 (2015): 701–7.

Doufas, A. G., et al. “The Hypothalamic-Pituitary-Thyroid Axis and the Female Reproductive System”. Annals of the New York Academy of Sciences 900 (2000): 65–76.

Dreon, D. M., et al. “Oral Contraceptive Use and Increased Plasma Concentration of C-reactive Protein”. Life Sciences 73, no. 10 (2003): 1245–52.

Ervin, K. S., et al. “Estrogen Involvement in Social Behavior in Rodents: Rapid and Long- Term Actions”. Hormones and Behavior 74 (2015): 53–76.

Fröhlich, M., et al. “Oral Contraceptive Use Is Associated with a Systemic Acute Phase Response”. Fibrinolysis and Proteolysis 13, no. 6 (1999): 239–44.

Graham, B. M., et al. “Blockade of Estrogen by Hormonal Contraceptives Impairs Fear Extinction in Female Rats and Women”. Biological Psychiatry 73, no. 4 (2013): 371–78.

Kabat-Zinn, J., et al. “Effectiveness of a Meditation-Based Stress Reduction Program in the Treatment of Anxiety Disorders”. American Journal of Psychiatry 149, no. 7 (1992): 936–43.

Kessler, R. C. “Epidemiology of Women and Depression”. Journal of Affective Disorders 74, no. 1 (2003): 5–13.

Klein, S. L., et al. “Sex Differences in Immune Responses”. Nature Reviews Immunology 16, no. 10 (2016): 626–38.

Kovats, S. “Estrogen Receptors Regulate Innate Immune Cells and Signaling Pathways”. Cellular Immunology 294, no. 2 (2015): 63–69.

Lakhan, S. E., et al. “Nutritional and Herbal Supplements for Anxiety and Anxiety-Related Disorders: A Systematic Review”. Nutrition Journal 9 (2010): 42.

Liu, X., et al. “Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet”. Journal of Agricultural and Food Chemistry 63, no. 36 (2015): 7885–95.

Maeng, L. Y., et al. “Sex Differences in Anxiety Disorders: Interactions Between Fear, Stress, and Gonadal Hormones”. Hormones and Behavior 76 (2015): 106–17.

Mao, J. J., et al. “Rhodiola Rosea Versus Sertraline for Major Depressive Disorder: A Randomized Placebo-Controlled Trial”. Phytomedicine 22, no. 3 (2015): 394–99.

Meier, T. B., et al. “Kynurenic Acid Is Reduced in Females and Oral Contraceptive Users: Implications for Depression”. Brain, Behavior, and Immunity 67 (2018): 59–64.

Miller, A. H., et al. “The Role of Inflammation in Depression: From Evolutionary Imperative to Modern Treatment Target”. Nature Reviews: Immunology 16, no. 1 (2015): 22–34.

Montoya, E. R., et al. “How Oral Contraceptives Impact Social-Emotional Behavior and Brain Function”. Trends in Cognitive Sciences 21, no. 2 (2017): 125–36.

Nehlig, A. “Effects of Coffee/Caffeine on Brain Health and Disease: What Should I Tell My Patients?” Practical Neurology 16, no. 2 (2016): 89–95.

Palmery, M., et al. “Oral Contraceptives and Changes in Nutritional Requirements”. European Review for Medical and Pharmacological Sciences 17, no. 13 (2013): 1804–13.

Pletzer, B. A., et al. “50 Years of Hormonal Contraception: Time to Find Out, What It Does to Our Brain”. Frontiers in Neuroscience 8, no. 8 (2014): 256.

https://www.frontiersin.org /articles/10.3389/fnins.2014.00256/full.

Quaranta, S., et al. “Pilot Study of the Efficacy and Safety of a Modified-Release Magnesium 250 mg Tablet (Sincromag) for the Treatment of Premenstrual Syndrome”. Clinical Drug Investigation 27, no. 1 (2007): 51–58.

Rifai, N., et al. “Population Distributions of C-Reactive Protein in Apparently Healthy Men and Women in the United States: Implication for Clinical Interpretation”. Clinical Chemistry 49, no. 4 (2003): 666–69.

Scheele, D., et al. “Hormonal Contraceptives Suppress Oxytocin-Induced Brain Reward Responses to the Partner’s Face”. Social Cognitive and Affective Neuroscience 11, no. 5 (2016): 767–74.

Skovlund, C. W., et al. “Association of Hormonal Contraception with Depression”. JAMA Psychiatry 73, no. 11 (2016): 1154–62.

Skovlund, C. W., et al. “Association of Hormonal Contraception with Suicide Attempts and Suicides”. American Journal of Psychiatry 175, no. 4 (2018): 336–42.

Smith, C., et al. “A Randomised Comparative Trial of Yoga and Relaxation to Reduce Stress and Anxiety”. Complementary Therapies in Medicine 15, no. 2 (2007): 77–83.

Sorensen, C. J., et al. “Combined Oral Contraception and Obesity Are Strong Predictors of Low-Grade Inflammation in Healthy Individuals: Results from the Danish Blood Donor Study (DBDS)”. PLoS One 9, no. 2 (2014): e88196.

Stomati, M., et al. “Contraception as Prevention and Therapy: Sex Steroids and the Brain”. European Journal of Contraception and Reproductive Health Care 3, no. 1 (1998): 21–28.

Ushiroyama, T., et al. “A Case of Panic Disorder Induced by Oral Contraceptive”. Acta Obstetricia et Gynecologica Scandinavica 71, no. 1 (1992): 78–80.

Van Wingen, G. A., et al. “Gonadal Hormone Regulation of the Emotion Circuitry in Humans”. Neuroscience 191 (2011): 38–45.

Worly, B. L., et al. “The Relationship Between Progestin Hormonal Contraception and Depression: A Systematic Review”. Contraception 97, no. 6 (2018): 478–89.

Yoto, A., et al. “Effects of L-Theanine or Caffeine Intake on Changes in Blood Pressure Under Physical and Psychological Stresses”. Journal of Physiological Anthropology 31 (2012): 28.

10. Поддержите свое либидо и репродуктивную функцию

Badawy, A., et al. “N-Acetylcysteine and Clomiphene Citrate for Induction of Ovulation in Polycystic Ovary Syndrome: A Cross-over Trial”. Acta Obstetricia et Gynecologica Scandinavica 86, no. 2 (2007): 218–22.

Baker, F. C., et al. “Circadian Rhythms, Sleep, and the Menstrual Cycle”. Sleep Medicine 8, no. 6 (2007): 613–22.

Bentzen, J. G., et al. “Ovarian Reserve Parameters: A Comparison Between Users and Non- users of Hormonal Contraception”. Reproductive BioMedicine Online 25, no. 6: 612–19.

Blackwell. “Oral Contraceptive Pill May Prevent More than Pregnancy: Could Cause Long- Term Problems with Testosterone”. ScienceDaily. January 5, 2006.

www.sciencedaily.com /releases/2006/01/060104232338.htm.

Bonnyns, M., et al. “Thyroid Gland and Female Sexual Function. I. Relation Outside of Pregnancy”. [In French.] Journal de Gynécologie, Obstétrique, et Biologie de la Reproduction 11, no. 4 (1982): 457–69.

Cheraghi, E., et al. “N-Acetylcysteine Improves Oocyte and Embryo Quality in Polycystic Ovary Syndrome Patients Undergoing Intracytoplasmic Sperm Injection: An Alternative to Metformin”. Reproduction, Fertility, and Development 28, no. 6 (2016): 723–31.

Coulam, C. B., et al. “Ultrasonographic Predictors of Implantation After Assisted Reproduction”. Fertility and Sterility 62, no. 5 (1994): 1004–10.

Cutler, W. B., et al. “Sexual Behavior Frequency and Biphasic Ovulatory Type Menstrual Cycles”. Physiology and Behavior 34, no. 5 (1985): 805–10.

Cutler, W. B., et al. “Sexual Behavior Frequency and Menstrual Cycle Length in Mature Premenopausal Women”. Psychoneuroendocrinology 4 (1979): 297–309.

https://www.athenainstitute.com/sciencelinks/sexualbehaviorfrequency1979.html.

De Flora, S., et al. “Attenuation of Influenza-like Symptomatology and Improvement of Cell- Mediated Immunity with Long-Term N-Acetylcysteine Treatment”. European Respiratory Journal 10, no. 7 (1977): 1535–41.

Deligdisch, L. “Hormonal Pathology of the Endometrium”. Modern Pathology 13, no. 3 (2000): 285–94.

Dewailly, D., et al. “The Physiology and Clinical Utility of Anti-Müllerian Hormone in Women”. Human Reproduction Update 20, no. 3 (2014): 370–85.

Dording, C. M., et al. “A Double-Blind Placebo-Controlled Trial of Maca Root as Treatment for Antidepressant-Induced Sexual Dysfunction in Women”. Evidence-Based Complementary and Alternative Medicine 2015 (2015): 949036.

Dorr, N. “Fertility Awareness and the Ovulation Method: Natural Birth Control”. Well-Being 35 (1978): 18–24.

Evans, J. L., et al. “The Molecular Basis for Oxidative Stress-Induced Insulin Resistance”. Antioxidants and Redox Signaling 7, nos. 7–8 (2005): 1040–52.

Fernando, S., et al. “Melatonin: Shedding Light on Infertility? – A Review of the Recent Literature”. Journal of Ovarian Research 7 (2014): 98.

Fouany, M. R., et al. “Is There a Role for DHEA Supplementation in Women with Diminished Ovarian Reserve?” Journal of Assisted Reproduction and Genetics 30, no. 9 (2013): 1239–44.

Fulghesu, A. M., et al. “N-Acetylcysteine Treatment Improves Insulin Sensitivity in Women with Polycystic Ovary Syndrome”. Fertility and Sterility 77, no. 6 (2002): 1128–35.

Grow, D. R., et al. “Oral Contraceptives Maintain a Very Tin Endometrium Before Operative Hysteroscopy”. Fertility and Sterility 85, no. 1 (2006): 204–7.

Harvey, S. M. “Female Sexual Behavior: Fluctuations During the Menstrual Cycle”. Journal of Psychosomatic Research 31, no. 1 (1987): 101–10.

Hvidman, H. W., et al. “Anti-Müllerian Hormone Levels and Fecundability in Women with a Natural Conception”. European Journal of Obstetrics, Gynecology, and Reproductive Biology 217 (2017): 44–52.

Johnson, L. N., et al. “Antimüllerian Hormone and Antral Follicle Count Are Lower in Female Cancer Survivors and Healthy Women Taking Hormonal Contraception”. Fertility and Sterility 102, no. 3 (2014): 774–81.e3.

Kallio, S., et al. “Antimüllerian Hormone Levels Decrease in Women Using Combined Contraception Independently of Administration Route”. Fertility and Sterility 99, no. 5 (2013): 1305–10.

Kovacs, P., et al. “The Effect of Endometrial Thickness on IVF/ICSI Outcome”. Human Reproduction 18, no. 11 (2003): 2337–41.

Legros, J. J. “Inhibitory Effect of Oxytocin on Corticotrope Function in Humans: Are Vasopressin and Oxytocin Ying-Yang Neurohormones?” Psychoneuroendocrinology 26, no. 7 (2001): 649–55.

Lisofsky, N. “Hormonal Contraceptive Use Is Associated with Neural and Affective Changes in Healthy Young Women”. NeuroImage 134 (2016): 597–606.

Lorenz, T. K., et al. “Interaction of Menstrual Cycle Phase and Sexual Activity Predicts Mucosal and Systemic Humoral Immunity in Healthy Women”. Physiology and Behavior 152, pt. A (2015): 92–98.

Lorenz, T. K., et al. “Partnered Sexual Activity Moderates Menstrual Cycle – Related Changes in Inflammation Markers in Healthy Women: An Exploratory Observational Study”. Fertility and Sterility 107, no. 3 (2017): 763–73.e3.

Lorenz, T. K. A., et al. “Sexual Activity Modulates Shifts in TH1/TH2 Cytokine Profile Across the Menstrual Cycle: An Observational Study”. Fertility and Sterility 104, no. 6 (2015): 1513–21.e4.

Lorenz, T. K., et al. “Testosterone and Immune-Reproductive Tradeoffs in Healthy Women”. Hormones and Behavior 88 (2017): 122–130.

Magon, N., et al. “The Orgasmic History of Oxytocin: Love, Lust, and Labor”. Indian Journal of Endocrinology and Metabolism 15, suppl. 3 (2011): S156–61.

Masha, A., et al. “Prolonged Treatment with N-Acetylcysteine and L-Arginine Restores Gonadal Function in Patients with Polycystic Ovary Syndrome”. Journal of Endocrinological Investigation 32, no. 11 (2009): 870–72.

Montoya, E. R., et al. “How Oral Contraceptives Impact Social-Emotional Behavior and Brain Function”. Trends in Cognitive Sciences 21, no. 2 (2017): 125–36.

Nassaralla, C. L., et al. “Characteristics of the Menstrual Cycle After Discontinuation of Oral Contraceptives”. Journal of Women’s Health 20, no. 2 (2011): 169–77.

Ohno, Y., et al. “Endometrial Oestrogen and Progesterone Receptors and Their Relationship to Sonographic Appearance of the Endometrium”. Human Reproduction Update 4, no. 5 (1998): 560–64.

Oner, G., et al. “Clinical, Endocrine, and Metabolic Effects of Metformin vs. N-Acetylcysteine in Women with Polycystic Ovary Syndrome”. European Journal of Obstetrics and Gynecology and Reproductive Biology 159, no. 1 (2011): 127–31.

Panjari, M., et al. “DHEA for Postmenopausal Women: A Review of the Evidence”. Maturitas 66, no. 2 (2010): 172–79.

Parry, B. L., et al. “Circadian Rhythms of Prolactin and Thyroid-Stimulating Hormone During the Menstrual Cycle and Early Versus Late Sleep Deprivation in Premenstrual Dysphoric Disorder”. Psychiatry Research 62, no. 2 (1996): 147–60.

Parry, B. L., et al. “Sleep, Rhythms, and Women’s Mood. Part I. Menstrual Cycle, Pregnancy, and Postpartum”. Sleep Medicine Reviews 10, no. 2 (2006): 129–44.

Petersen, K. B., et al. “Ovarian Reserve Assessment in Users of Oral Contraception Seeking Fertility Advice on Their Reproductive Lifespan”. Human Reproduction 30, no. 10 (2015): 2364–75.

Resnik, S. S. “Melasma and Other Skin Manifestations or Oral Contraceptives”. Transactions of the New England Obstetrical and Gynecological Society 21 (1967): 101–7.

Smith, G. D., et al. “Sex and Death: Are They Related? Findings from the Caerphilly Cohort Study”. British Medical Journal 315, no. 7123 (1997): 1641–44.

Soltan, M. H., et al. “Outcome in Patients with Post-Pill Amenorrhea”. British Journal of Obstetrics and Gynaecology 89, no. 9 (1982): 745–48.

Talukdar, N., et al. “Effect of Long-Term Combined Oral Contraceptive Pill Use on Endometrial Thickness”. Obstetrics and Gynecology 120, no. 2, pt. 1 (2012): 348–54.

https://journals.lww.com/greenjournal/Fulltext/2012/08000/Effect_of_Long_Term _Combined_Oral_Contraceptive.23.aspx.

Tofoletto, S., et al. “Emotional and Cognitive Functional Imaging of Estrogen and Progesterone Effects in the Female Human Brain: A Systematic Review”. Psychoneuroendocrinology 50 (2014): 28–52.

Wallwiener, C. W., et al. “Prevalence of Sexual Dysfunction and Impact of Contraception in Female German Medical Students”. Journal of Sexual Medicine 7, no. 6 (2010): 2139–48.

13. Альтернативные методы контрацепции

American College of Obstetricians and Gynecologists. “Barrier Methods of Birth Control”. Last modified March 2018. Accessed on August 28, 2017. https://www.acog.org/Patients /FAQs/Barrier-Methods-of-Birth-Control-Spermicide-Condom-Sponge-Diaphragm – and-Cervical-Cap.

Arévalo, M., et al. “A Fixed Formula to Define the Fertile Window of the Menstrual Cycle as the Basis of a Simple Method of Natural Family Planning”. Contraception 60, no. 6 (1999): 357–60.

Arévalo, M., et al. “Application of Simple Fertility Awareness-Based Methods of Family Planning to Breastfeeding Women”. Fertility and Sterility 80, no. 5 (2003): 1241–48.

Arévalo, M., et al. “Efficacy of a New Method of Family Planning: The Standard Days Method”. Contraception 65, no. 5 (2002): 333–38.

Cervical Barrier Advancement Society. “Contraceptive Efficacy Rates for Cervical Barriers and Other Barriers”. Accessed August 28, 2017. http://www.cervicalbarriers.org /information/efcacyRates.htm. Curtis, K. M., et al. “U.S. Selected Practice Recommendations for Contraceptive Use”. MMWR Recommendations and Reports 65, no. 4 (2016): 1–66.

Duane, M., et al. “The Performance of Fertility Awareness-Based Method Apps Marketed to Avoid Pregnancy”. Journal of the American Board of Family Medicine 29, no. 4 (2016): 508–11.

Farley, T. M. M., et al. “Intrauterine Devices and Pelvic Inflammatory Disease: An International Perspective”. Lancet 339, no. 8796 (1992): 785–88. Ferrell, R. J., et al. “The Length of Perimenopausal Menstrual Cycles Increases Later and to a Greater Degree than Previously Reported”. Fertility and Sterility 86, no. 3 (2006): 619–24.

Fihn, S. D., et al. “Association Between Use of Spermicide-Coated Condoms and Escherichia Coli Urinary Tract Infection in Young Women”. American Journal of Epidemiology 144, no. 5 (1996): 512–20. Frank-Herrmann, P., et al. “The Effectiveness of a Fertility Awareness Based Method to Avoid Pregnancy in Relation to a Couple’s Sexual Behaviour During the Fertile Time: A Prospective Longitudinal Study”. Human Reproduction 22, no. 5 (2007): 1310–19.

Gallo, M. F., et al. “Cervical Cap Versus Diaphragm for Contraception”. Cochrane Database of Systematic Reviews 2002, no. 4 (2002): CD003551.

Hatcher, R. A. Contraceptive Technology. 20th ed. Decatur, IL: Bridging the Gap Communications, 2011.

Mauck, C., et al. “A Comparative Study of the Safety and Efficacy of FemCap, A New Vaginal Barrier Contraceptive, and the Ortho All-Flex Diaphragm”. Contraception 60, no. 2 (1999): 71–80.

Sinai, I., et al. “The TwoDay Algorithm: A New Algorithm to Identify the Fertile Time of the Menstrual Cycle”. Contraception 60, no. 2 (1999): 65–70.

Teal, S. B., et al. “Insertion Characteristics of Intrauterine Devices in Adolescents and Young Women: Success, Ancillary Measures, and Complications”. American Journal of Obstetrics and Gynecology 213, no. 4 (2015): 515.e1–5.

Trussell, J. “Contraceptive Failure in the United States”. Contraception 83, no. 5 (2011): 397–404.

Trussell, J., et al. “The Creeping Pearl: Why Has the Rate of Contraceptive Failure Increased in Clinical Trials of Combined Hormonal Contraceptive Pills?” Contraception 88, no. 5 (2013): 604–10.

Trussell, J., et al. “Further Analysis of Contraceptive Failure of the Ovulation Method”. American Journal of Obstetrics and Gynecology 165, no. 6, pt. 2 (1991): 2054–59.

Weschler, T. Taking Charge of Your Fertility: The Definitive Guide to Natural Birth Control, Pregnancy Achievement, and Reproductive Health, 20th Anniversary Edition. New York: William Morrow, 2015.

World Health Organization. “A Prospective Multicentre Trial of the Ovulation Method of Natural Family Planning. I. The Teaching Phase”. Fertility and Sterility 36, no. 2 (1981): 152–58.

Назад: Приложения

Дальше: Благодарности